NCT00501644 - Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Ovarian CancerFallopian Tube CancerPeritoneal Cancer

Interventions

DRUG

Carboplatin

AUC of 5 by 1 hour IV infusion every 28 days.

DRUG

GM-CSF (Sargramostim)

Starting dose of 400 mg injected under the skin once a day for 7 days prior to and following each course of chemotherapy.

DRUG

Interferon Gamma

0.1 mg injected under the skin for 2 days before and after chemotherapy (Day 5 and Day 7 of each 7-day GM-CSF cycle).

Trial Locations (1)

U.T.M.D. Anderson Cancer Center, Houston